Fovepta

Fovepta Adverse Reactions

hepatitis b immunoglobulin

Manufacturer:

Marketer:

Pharmasolindo

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Adverse Reactions

Fovepta has been studied in a clinical trial with 34 neonates. There are no robust data on the frequency of undesirable effects from this clinical trial, however, the following are known to be associated with hepatitis-B immunoglobulins: See table.

Click on icon to see table/diagram/image

For safety with respect to transmissible agents, see Precautions.

View ADR Monitoring Form

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in